Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia (IMPACT-AD BC)

NCT05002699 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05002699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05002699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia (IMPACT-AD BC)
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2019
Completion date
March 31, 2023
Enrollment
120 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, dementia, mild cognitive impairment